Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.33 |
| ▸ | PRKCG | P05129 | 2/20 | 0.33 |
| ▸ | PRKCB | P05771 | 2/20 | 0.33 |
| ▸ | PRKCA | P17252 | 2/20 | 0.33 |
| ▸ | PRKCH | P24723 | 2/20 | 0.33 |
| ▸ | PRKCI | P41743 | 2/20 | 0.33 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.33 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.33 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.33 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.33 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16541448 | 0.78 | PRKD3 (0.34) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL2863037 | 0.76 | — | — | |
| SCHEMBL2863035 | 0.76 | — | — | |
| SCHEMBL8134196 | 0.76 | — | — | |
| SCHEMBL252279 | 0.74 | — | — | |
| SCHEMBL4876623 | 0.73 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL11631029 | 0.73 | PRKD3 (0.36) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL10817323 | 0.73 | ALDH1A1 (0.37) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL19694 | 0.73 | PRKD3 (0.36) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL11630861 | 0.73 | PRKD3 (0.36) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2382199-B1 | KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS | GFBIOCHEMICALS LTD (MT) | 2016-11-16 | — | — | EP | disclosed |
| US-20130053564-A1 | KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS | SEGETIS, INC. (US) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053564-A1 | KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS | KAT6A, KAT6B, KAT5 | PRKD3 1307/4885PRKCG 1222/4885PRKCB 1266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.